Search Result "striatopallidal"


Glutamate mGlu5-Adenosine A2A-Dopamine D2 Receptor Interactions in the Striatum. Implications for Drug Therapy in Neuro-psychiatric Disorders and Drug Abuse

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 3 Issue: 1 Year: 2003 Page: 1-26
Author(s): Sergi Ferre, Francisco Ciruela, Amina S. Woods, Meritxell Canals, Javier Burgueno, Daniel Marcellino, Marzena Karcz-Kubicha, Bruce T. Hope, Marisela Morales, Patrizia Popoli, Steven R. Goldberg, Kjell Fuxe, Carme Lluis, Rafael Franco, Luigi Agnati

Targeting Endogenous Mu- and Delta-Opioid Receptor Systems for the Treatment of Drug Addiction

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7 Issue: 5 Year: 2008 Page: 442-453
Author(s): T. S. Shippenberg, A. LeFevour, V. I. Chefer

Neurotensin NTS1-Dopamine D2 Receptor-Receptor Interactions in Putative Receptor Heteromers: Relevance for Parkinson`s Disease and Schizophrenia

Journal: Current Protein & Peptide Science
Volume: 15 Issue: 7 Year: 2014 Page: 681-690
Author(s): Luca Ferraro,Sarah Beggiato,Dasiel O. Borroto-Escuela,Laura Ravani,William T. O'Connor,Maria C. Tomasini,Andrea C. Borelli,Luigi F. Agnati,Tiziana Antonelli,Sergio Tanganelli,Kjell Fuxe

Adenosine A2A Receptor Antagonists and Parkinsons Disease: State of the Art and Future Directions

Journal: Current Pharmaceutical Design
Volume: 14 Issue: 1 Year: 2008 Page: 1475-1489
Author(s): N. Simola, M. Morelli, A. Pinna

Regulation of Corticostriatal Synaptic Plasticity by G Protein-Coupled Receptors

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9 Issue: 5 Year: 2010 Page: 601-615
Author(s): Rakel Lopez de Maturana, Rosario Sanchez-Pernaute

An Update on Adenosine A2A Receptors as Drug Target in Parkinsons Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10 Issue: 6 Year: 2011 Page: 659-669
Author(s):

Letter Article open access plus

Challenges in the Discovery and Optimization of mGlu2/4 Heterodimer Positive Allosteric Modulators

Journal: Letters in Drug Design & Discovery
Volume: 16 Issue: 1 Year: 2019 Page: 1387-1394
Author(s): Mark Gallant Fulton,Matthew Thomas Loch,Caroline Anne Cuoco,Alice Lambert Rodriguez,Emily Days,Paige Newton Vinson,Krystian Andrezej Kozek,Charles David Weaver,Anna Louise Blobaum,Peter Jeffrey Conn,Colleen Marie Niswender,Craig William Lindsley

PDE10A Inhibitors: Novel Therapeutic Drugs for Schizophrenia

Journal: Current Pharmaceutical Design
Volume: 17 Issue: 2 Year: 2011 Page: 137-150
Author(s): Jan Kehler, Jacob Nielsen

Postmortem-Assessed Impairment of Neuronal Activity in Depression: The Dominant Impact of Suicide

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12 Issue: 7 Year: 2013 Page: 930-935
Author(s): Tomasz Gos,Johann Steiner,Zbigniew Jankowski,Bernhard Bogerts

General Research Article

6-hydroxydopamine Lesion of the Mesolimbic Dopamine System Alters Morphine-Induced Conditioned Reinforcement

Journal: Current Psychopharmacology
Volume: 7 Issue: 1 Year: 2018 Page: 83-90
Author(s): S. Tiffany Donaldson,Brooke Plotkin

Previous   Next

Go To   Results 1 - 1 of 112

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy